Insys Therapeutics Inc. (NEOL) Profile

Profile for Insys Therapeutics Inc. (NEOL)


Business Description: Insys Therapeutics, Inc. is a specialty pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care.

Address:	10220 South 51st Street, Suite 2, Phoenix, AZ, 85044
Telephone:	(602) 910-2617	Website:	www.insysrx.com
Facsimile:	(602) 910-2627	Email:	investorrelations@neopharm.com


Details

CEO:	Laurence P. Birch
Employees:	17	Market Cap:	6.31 m
Issue Type:	CS
Auditor:	BDO Seidman, LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0000942788
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Biological Product (except Diagnostic) Manufacturing (325414)
SIC:	Biological Products, Except Diagnostic Substances (2836)

Tags for Insys Therapeutics Inc.

Research stocks or mutual funds related to Insys Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to NEOL. The keywords below have been associated to NEOL by either user submission or electronic means.

advanced therapy clinical trials database nasal drug delivery types of brain tumor pharmaceutical market pivotal therapy system new drug delivery systems hr strategy Biological Products pharma manufacturing pharma license phase iii clinical trials Brain tumor drug delivery pharmaceutical cro pharma consulting malignant astrocytoma drug absorption clinical trials industry pharmaceutical distributors pharma in licensing licensing companies pharmaceutical development topical drug delivery pharmaceutical magazine pharmaceutical consultant biotechnology licensing worldwide clinical trials Drugs pharma clinical trials pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation hairy cell leukemia therapy contract pharmaceutical pharmaceutical industry clinical trials europe cancer veterinary pharmaceutical pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development Healthcare pharmaceutical sector neopharm drug delivery systems pharmaceutical industry research controlled drug delivery

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.